Clinical trial
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple…
NCT00002850 · Gary Morrow, Other · Completed
Key facts
| NCT number | NCT00002850 |
|---|---|
| Title | Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy |
| Official title | Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma |
| Lead sponsor | Gary Morrow, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infection, Multiple Myeloma |
| Intervention type | Drug |
| Interventions | ciprofloxacin, ofloxacin, 160 mg trimethoprim and 800 mg sulfamethoxazole |
| Enrollment | 212 |
| Start date | Mar 1, 1997 |
| Primary completion | Apr 1, 2011 |
| Completion | Jan 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 11, 2015 |
| Countries | Peru, South Africa, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: